Slingshot members are tracking this event:
Ardelyx'S Plans to Initiate The Second Phase 3 Study of Tenapanor for The Treatment Of Hyperphosphatemia in ESRD Patients on Dialysis in Mid-2017
Slingshot Insights Explained
Feb 15, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 3, Tenapanor, End-stage Renal Disease, Esrd, Hyperphosphatemia